Garcia-Saenz JA, Marme F, Untch M, Bonnefoi H, et al. Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPE(B) study. Eur J Cancer 2023;196:113420.
PMID: 38000218